Cullinan Therapeutics CSO to join MITCEO Conference panel on advancing patient medicines

Cullinan Therapeutics CSO to join MITCEO Conference panel on advancing patient medicines
Cullinan CSO to join MITCEO panel

Cullinan Therapeutics announced that Chief Scientific Officer Jennifer Michaelson, PhD, will participate in a discussion at the Longwood Healthcare Leaders MITCEO Conference next Tuesday.

The event brings together prominent leaders from the life sciences sector to explore strategies that accelerate the development of new medicines for patients. Michaelson's involvement highlights the company's commitment to scientific advancement and collaboration within the healthcare industry.

Cullinan Therapeutics has recently outlined a novel biomarker approach aimed at immune reset in autoimmune diseases. The company has also pursued the development of T cell engager therapies targeting B cells. These initiatives reflect Cullinan's advancing research in autoimmune treatment.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.